A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions

Carcinogenesis

Volumn 29, Issue 10, 2008, Pages 1950-1954

  Welsh, Marleen M ^a   Karagas, Margaret R ^b   Applebaum, Katie M ^a   Spencer, Steven K ^c   Perry, Ann E ^c   Nelson, Heather H ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; HISTIDINE AMMONIALYASE; UROCANIC ACID;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CONTROLLED STUDY; ECOLOGICAL GENETICS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PHARMACOGENOMICS; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION INJURY; SEX DIFFERENCE; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SUNBURN; ULTRAVIOLET RADIATION;

ADULT; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CONTRACEPTIVES, ORAL; FEMALE; GENOTYPE; HISTIDINE AMMONIA-LYASE; HUMANS; IMMUNE TOLERANCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS; SUNBURN; ULTRAVIOLET RAYS; UROCANIC ACID;

EID: 53349171169     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn160     Document Type: Article

References (52)

1. Prater,M.R. (2003) Immunotoxic effects of cis-urocanic acid exposure in C57BL/6N and C3H/HeN mice. Photochem. Photobiol., 77, 383-389.
2. Hart,P.H. (1999) A critical role for dermal mast cells in cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses in mice. Photochem. Photobiol., 70, 807-812.
3. Hart,P.H. (1997) Histamine involvement in UVB- and cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses. Immunology, 91, 601-608.
4. Beissert,S. (2001) IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: Implications for photocarcinogenesis. J. Immunol., 167, 6232-6238.
5. Beissert,S. (1997) Regulation of tumor antigen presentation by urocanic acid. J. Immunol., 159, 92-96.
6. Khalil,Z. (2001) cis-Urocanic acid stimulates neuropeptide release from peripheral sensory nerves. J. Invest. Dermatol., 117, 886-891.
7. Moodycliffe,A.M. (1996) Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation. J. Inummol., 157, 2891-2899.
8. Noonan,F.P. et al. (1994) Susceptibility to immunosuppression by ultraviolet B radiation in the mouse. Immunogenetics, 39, 29-39.
9. Yoshikawa,T. (1990) Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol., 95, 530-536.
10. Venneer,M. (1991) Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J. Invest. Dermatol. 97, 729-734.
11. Streilein,J.W. et al. (1988) Genetic basis of ultraviolet-B effects on contact hypersensitivity. Immunogenetics, 27, 252-258.
12. Hanford,W.C. et al. (1977) Genetic differences in the rate of histidase synthesis in inbred mice. J. Biol. Chem., 252, 6695-6699.
13. Yoshikawa,T. et al. (1990) Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility. Immunogenetics, 32, 398-405.
14. Suchi,M. (1995) Molecular cloning and structural characterization of the human histidase gene (HAL). Genomics, 29, 98-104.
15. Hryb,D.J. et al. (1983) Nature of translational products, tissue specificity, and differential development in male and female rat liver. J. Biol. Chem., 258, 11377-11383.
16. Feigelson,M. (1968) Estrogenic regulation of hepatic histidase during post-natal development and adulthood. J. Biol. Chem., 243, 5088-5093.
17. Feigelson,M. (1973) Studies on the postnatal development of responses of hepatic histidase to endocrine control. Biochim. Biophys. Acta, 304, 669-685.
18. Bhargava,M.M. et al. (1976) Studies on the mechanisms of histidase development in rat skin and liver. II. Alterations in enzyme levels and synthetic rates during development. Dev. Biol., 48, 226-236.
19. Karagas,M.R. (1999) Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int. J. Cancer, 81, 555-559.
20. Karagas,M.R. (2001) Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol., 153, 559-565.
21. Miettinen,O.S. (1976) Stratification by a multivariate confounder score. Am. J. Epidemiol., 104, 609-620.
22. Cook,E.F. et al. (1989) Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity score. J. Clin. Epidemiol., 42, 317-324.
23. Miller,K.L. (2006) XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis, 27, 1670-1675.
24. Taylor,R.G. et al. (1994) Site-directed mutagenesis of conserved serines in rat histidase. Identification of serine 254 as an essential active site residue. J. Biol. Chem., 269, 27473-27477.
25. Rother,D. (2001) Characterization of the active site of histidine ammonia-lyase from Pseudomonas putida. Eur. J. Biochem., 268 6011-6019.
26. Baedeker,M. et al. (2002) Structures of two histidine ammonia-lyase modifications and implications for the catalytic mechanism. Eur. J. Biochem., 269, 1790-1797.
27. Baedeker,M. et al. (2002) Autocatalytic peptide cyclization during chain folding of histidine ammonia-lyase. Structure, 10, 61-67.
28. Ferrer-Costa,C. et al. (2004) Sequence-based prediction of pathological mutations. Proteins, 57, 811-819.
29. Morrison,H. (1985) Photochemistry and photobiology of urocanic acid. Photodermatol., 2, 158-165.
30. Standring,S. (ed.) 2004 Gray's Anatomy: The Anatomical Basis of Clinical Practice, 39th edn. C.V. Mosby, New York, NY, 39th edn 1627.
31. Thornton,M.J. (2003) The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit. J. Investig. Dermatol. Symp. Proc., 8, 100-103.
32. Pelletier,G. et al. (2004) Localization of sex steroid receptors in human skin. Histol. Histopathol., 19, 629-636.
33. Thornton,M.J. (2003) Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol., 12, 181-190.
34. Thornton,M.J. (2002) The biological actions of estrogens on skin. Exp. Dermatol., 11, 487-502.
35. Reaven,E.P. et al. (1967) The relationship of histochemically reactive histidine to histidase activity in the epidermis of growing rats. Anat. Rec., 158, 139-147.
36. Ulrich,C. (2004) Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol. Surg. 30, 622-627(4 Pt 2).
37. McCann,J. (1999) Can skin cancers be minimized or prevented in organ transplant patients? J. Natl Cancer Inst., 91, 911-913.
38. Miller-Applebaum,K. et al. (2005) Oral contraceptives and non-melanoma skin cancer. Environmental, Hormonal, and Genetic Risk Factors for Non-melanoma Skin Cancer [dissertation]. Harvard School of Public Health, Boston, MA.
39. English,D.R. et al. (1998) Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol. Biomarkers Prev., 7, 857-863.
40. Nischan,P. (1993) Comparison of recalled and validated oral contraceptive histories. Am. J. Epidemiol., 138, 697-703.
41. Karagas,M.R. (2001) Non-melanoma skin cancers and glucocorticoid therapy. Br. J. Cancer, 85, 683-686.
42. American Cancer Society. Cancer Facts and Figures 2007. American Cancer Society, Atlanta.
43. Housman,T.S. (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol., 48, 425-429.
44. Mosher,W.D. (2004) Use of contraception and use of family planning services in the United States: 1982-2002. Adv. Data, 1-36.
45. Schacke,H. et al. (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther., 96, 23-43.
46. Denkins,Y. et al. (1989) Exposure of mice to UV-B radiation suppresses delayed hypersensitivity to Candida albicans. Photochem. Photobiol., 49, 615-619.
47. Jeevan,A. et al. (1989) Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis bacillus Calmette-Guerin infection in mice. J. Immunol., 143, 2837-2843.
48. Giannini,M.S. (1986) Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation. Infect. Immun., 51, 838-843.
49. Howie,S. et al. (1986) Exposure to low-dose ultraviolet radiation suppresses delayed-type hypersensititity to herpes simplex virus in mice. J. Invest. Dermatol., 86, 125-128.
50. Ross,J.A. (1986) Ultraviolet-irradiated urocanic acid suppresses delayed-type hypersensitivity to herpes simplex virus in mice. J. Invest. Dermatol., 87, 630-633.
51. Sleijffers,A. (2003) Epidermal cis-urocanic acid levels correlate with lower specific cellular immune responses after hepatitis B vaccination of ultraviolet B-exposed humans. Photochem. Photobiol., 77, 271-275.
52. Vincek,V. (1995) Sunlight induced progression of AIDS. Med. Hypotheses, 44, 119-123.